| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049390272 |
| P356 | DOI | 10.1038/NPP.2010.226 |
| P932 | PMC publication ID | 3052624 |
| P698 | PubMed publication ID | 21160464 |
| P5875 | ResearchGate publication ID | 49685508 |
| P50 | author | David A. Baker | Q55729031 |
| Linda B Piacentine | Q59973880 | ||
| P2093 | author name string | Shi-Jiang Li | |
| John R Mantsch | |||
| Robert C Risinger | |||
| Muhammad E Ahmad | |||
| Shelley L Amen | |||
| P2860 | cites work | The assessment and analysis of handedness: The Edinburgh inventory | Q26778476 |
| The role of cystine-glutamate exchange in nicotine dependence in rats and humans | Q28566669 | ||
| Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism | Q33601673 | ||
| Anti-relapse medications: preclinical models for drug addiction treatment | Q33927470 | ||
| The reinstatement model and relapse prevention: a clinical perspective. | Q34062912 | ||
| Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats | Q34071804 | ||
| The validity of the reinstatement model of craving and relapse to drug use. | Q34190646 | ||
| Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine | Q34378304 | ||
| Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. | Q34411360 | ||
| Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans | Q34448716 | ||
| N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. | Q34990938 | ||
| Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure | Q35103785 | ||
| Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. | Q37038018 | ||
| N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking | Q37259319 | ||
| Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine | Q37533087 | ||
| The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine | Q43045616 | ||
| Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. | Q43505179 | ||
| Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans | Q43567791 | ||
| Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. | Q44419020 | ||
| Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse | Q44460612 | ||
| Neural responses to acute cocaine administration in the human brain detected by fMRI. | Q46629937 | ||
| N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study | Q48196146 | ||
| Acute effects of cocaine on human brain activity and emotion | Q48618466 | ||
| Is cocaine desire reduced by N-acetylcysteine? | Q50895493 | ||
| Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI. | Q51421996 | ||
| An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. | Q55042731 | ||
| Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine | Q68325233 | ||
| Pharmacokinetic and pharmacodynamic studies of N-acetylcysteine, a potential chemopreventive agent during a phase I trial | Q71861148 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 871-878 | |
| P577 | publication date | 2010-12-15 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans | |
| P478 | volume | 36 |
| Q35144056 | A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence |
| Q36137192 | A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. |
| Q34613783 | Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network |
| Q50541038 | Addictive behaviour in experimental animals: prospects for translation. |
| Q36234265 | Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function |
| Q91829923 | Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy |
| Q34420036 | Behavioral assessment of acute inhibition of system xc (-) in rats |
| Q47437172 | Beyond the "First Hit": Marked Inhibition by N-Acetyl Cysteine of Chronic Ethanol Intake But Not of Early Ethanol Intake. Parallel Effects on Ethanol-Induced Saccharin Motivation. |
| Q35161340 | Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking |
| Q39793952 | Chronic N-acetylcysteine after cocaine self-administration produces enduring reductions in drug-seeking |
| Q34868089 | Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking |
| Q60912864 | Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking |
| Q36852570 | Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse |
| Q38805967 | Corticostriatal circuitry in regulating diseases characterized by intrusive thinking |
| Q102147364 | Could N-acetylcysteine improve the safety of clozapine? |
| Q34289046 | Differences in rat dorsal striatal NMDA and AMPA receptors following acute and repeated cocaine-induced locomotor activation |
| Q41853424 | Different adaptations in AMPA receptor transmission in the nucleus accumbens after short vs long access cocaine self-administration regimens. |
| Q47339973 | Effect of N-acetylcysteine on motivation, seeking and relapse to ethanol self-administration. |
| Q35868906 | Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model |
| Q33764257 | Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine |
| Q38618048 | Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders |
| Q36390075 | Fronto-striatal circuits in response-inhibition: Relevance to addiction |
| Q22242633 | Future pharmacological treatments for substance use disorders |
| Q39101511 | Genetic studies of alcohol dependence in the context of the addiction cycle |
| Q26829556 | Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity? |
| Q43076075 | Glial and neuroinflammatory targets for treating substance use disorders |
| Q38729846 | Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse |
| Q28081726 | Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders |
| Q37871133 | Glutamatergic medications for the treatment of drug and behavioral addictions |
| Q99201953 | Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol |
| Q47284247 | Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior |
| Q50566963 | N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study. |
| Q41843975 | N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors. |
| Q47825865 | N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. |
| Q47404227 | N-acetylcysteine amide (AD4) reduces cocaine-induced reinstatement |
| Q36971440 | N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking |
| Q37072055 | N-acetylcysteine decreases binge eating in a rodent model |
| Q89841228 | N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial |
| Q34543171 | N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. |
| Q55032013 | N-acetylcysteine: A potential treatment for substance use disorders. |
| Q38060713 | Neuroplasticity in addiction: cellular and transcriptional perspectives. |
| Q35333393 | New medications for drug addiction hiding in glutamatergic neuroplasticity |
| Q34253787 | Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. |
| Q36930072 | Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.). |
| Q27324591 | Poor sensitization of 50-kHz vocalization response to amphetamine predicts rat susceptibility to self-administration of the drug. |
| Q28306130 | Potential role of N-acetylcysteine in the management of substance use disorders |
| Q26999059 | Rapid, transient synaptic plasticity in addiction |
| Q38674558 | Recent developments in the behavioural and pharmacological enhancement of extinction of drug seeking |
| Q47789766 | Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal |
| Q48250313 | Regulation of hippocampal synaptic strength by glial xCT. |
| Q27013753 | Role of nucleus accumbens glutamatergic plasticity in drug addiction |
| Q90337102 | Sex differences in the glutamate system: Implications for addiction |
| Q34184493 | System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. |
| Q57167598 | Targeting redox regulation to treat substance use disorder using N-acetylcysteine |
| Q37062547 | The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis |
| Q52616964 | The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats. |
| Q37121626 | The effects of cocaine on different redox forms of cysteine and homocysteine, and on labile, reduced sulfur in the rat plasma following active versus passive drug injections. |
| Q28534521 | The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice |
| Q37164797 | The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research |
| Q26864995 | Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling |
| Q41975077 | Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats |
| Q36875681 | Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche |
| Q26751118 | Ventral Tegmental Area Afferents and Drug-Dependent Behaviors |
Search more.